However, it has been recently reported that CALCRL, the receptor of ADM and CGRP, is also overexpressed in LSC and its genomic ablation impaired the clonogenic capacity of AML cell lines (50) and the frequency of chemotherapy-resistant cells able to initiate leukemia relapse in preclinical models (81). This evidence concerns the gene ADM and acute myeloid leukemia.